A Systematic Comparison of Microsimulation Models of Colorectal Cancer
暂无分享,去创建一个
Iris Lansdorp-Vogelaar | Marjolein van Ballegooijen | Amy B. Knudsen | E. Feuer | A. Zauber | J. Savarino | C. Rutter | K. Kuntz | M. van Ballegooijen | I. Lansdorp-Vogelaar | A. Knudsen | Amy B. Knudsen | Carolyn M. Rutter | Karen M. Kuntz | Eric J. Feuer | Ann G. Zauber | James E. Savarino | Eric J. Feuer
[1] U. P. S. T. Force,et al. Screening for Colorectal Cancer: Recommendation and Rationale , 2002, Annals of Internal Medicine.
[2] S. Winawer,et al. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. , 1987, Gastroenterology.
[3] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.
[4] J. Bombí,et al. Polyps of the colon in barcelona, Spain. An autopsy study , 1988, Cancer.
[5] P. J. Young,et al. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. , 1992, Gut.
[6] T C ARMINSKI,et al. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations , 1964, Diseases of the colon and rectum.
[7] Robert J. Mayer,et al. Erratum: Colorectal cancer screening: Clinical guidelines and rationale (Gastroenterology (1997) 112 (594-642)) , 1997 .
[8] P C Prorok,et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.
[9] I CHAPMAN,et al. Adenomatous Polypi of Large Intestine: Incidence and Distribution , 1963, Annals of surgery.
[10] J W BAKER,et al. Polyps of the colon. , 1962, Surgery, gynecology & obstetrics.
[11] Grace Huang,et al. Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis , 2001, Annals of Internal Medicine.
[12] Hermann Brenner,et al. Cost-effectiveness of colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.
[13] Graham A. Colditz,et al. Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.
[14] C. Crosta,et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. , 2002, Journal of the National Cancer Institute.
[15] Amy B. Knudsen,et al. Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population , 2010, Annals of Internal Medicine.
[16] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[17] L M Schuman,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.
[18] A. Noffsinger. Serrated polyps and colorectal cancer: new pathway to malignancy. , 2009, Annual review of pathology.
[19] C. Johnson,et al. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. , 1998, AJR. American journal of roentgenology.
[20] T. Church,et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.
[21] C. Mulrow,et al. Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.
[22] S. Woolf,et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.
[23] T. Church,et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.
[24] Michael Pignone,et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. , 2002, Annals of internal medicine.
[25] Susan J. Curry,et al. Fulfilling the Potential of Cancer Prevention and Early Detection , 2003 .
[26] B. Morson. The pathogenesis of colorectal cancer. Introduction. , 1978, Major problems in pathology.
[27] Michael Pignone,et al. Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults , 2005 .
[28] R. Hayward,et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.
[29] Amy B. Knudsen,et al. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. , 2010, Journal of the National Cancer Institute.
[30] Robert A Smith,et al. American Cancer Society Guidelines for the Early Detection of Cancer, 2006 , 2006, CA: a cancer journal for clinicians.
[31] N. O. Jacobsen,et al. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. , 1989, Scandinavian journal of gastroenterology.
[32] Lester J. Blatt,et al. Polyps of the colon and rectum , 1961 .
[33] Yrjö Collan,et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large‐bowel cancer , 1985, International journal of cancer.
[34] P. Maisonneuve,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.
[35] J. Olsen,et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.
[36] David K Whynes,et al. Cost-Effectiveness of Screening for Colorectal Cancer: Evidence from the Nottingham Faecal Occult Blood Trial , 2004, Journal of medical screening.
[37] A. Joseph,et al. Cost effectiveness of HemoQuant versus hemoccult for colorectal cancer screening , 1988, Journal of General Internal Medicine.
[38] M. Vatn,et al. The prevalence of polyps of the large intestine in Oslo: An autopsy study , 1982, Cancer.
[39] E. C. Hammond,et al. Adenomatous lesions of the large bowel: An autopsy survey , 1979, Cancer.
[40] Bernadette Mazurek Melnyk,et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.
[41] Carolyn M. Rutter,et al. Clarifying Differences in Natural History between Models of Screening , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[42] Rob Boer,et al. The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..
[43] B. Levin,et al. American Cancer Society Guidelines for the Early Detection of Cancer , 2002, CA: a cancer journal for clinicians.
[44] B. Morson. The pathogenesis of colorectal cancer , 1978 .
[45] Cancer,et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.
[46] Amy B. Knudsen,et al. Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.
[47] D W Day,et al. Polyps and cancer of the large bowel: a necropsy study in Liverpool. , 1982, Gut.
[48] Robert W. Klein,et al. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages , 2000 .
[49] M. Bretthauer,et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial , 2009, BMJ : British Medical Journal.
[50] J. Wagner,et al. Cost effectiveness of colorectal cancer screening in the elderly. , 1991, Annals of internal medicine.
[51] J. Mitchell,et al. A DECISION MODEL AND COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS , 2000, International Journal of Technology Assessment in Health Care.
[52] S. Moss,et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.